Your browser doesn't support javascript.
loading
Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity.
O'Donnell, Joanne A; Lehman, Jesse; Roderick, Justine E; Martinez-Marin, Dalia; Zelic, Matija; Doran, Ciara; Hermance, Nicole; Lyle, Stephen; Pasparakis, Manolis; Fitzgerald, Katherine A; Marshak-Rothstein, Ann; Kelliher, Michelle A.
Affiliation
  • O'Donnell JA; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605.
  • Lehman J; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605.
  • Roderick JE; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605.
  • Martinez-Marin D; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605.
  • Zelic M; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605.
  • Doran C; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605.
  • Hermance N; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605.
  • Lyle S; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605.
  • Pasparakis M; Institute for Genetics, Center for Molecular Medicine, University of Cologne, 50931 Cologne, Germany.
  • Fitzgerald KA; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, 50931 Cologne, Germany; and.
  • Marshak-Rothstein A; Program in Innate Immunity, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605.
  • Kelliher MA; Program in Innate Immunity, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605.
J Immunol ; 200(2): 737-748, 2018 01 15.
Article in En | MEDLINE | ID: mdl-29212904
ABSTRACT
Necroptosis is a form of cell death associated with inflammation; however, the biological consequences of chronic necroptosis are unknown. Necroptosis is mediated by RIPK1, RIPK3, and MLKL kinases but in hematopoietic cells RIPK1 has anti-inflammatory roles and functions to prevent necroptosis. Here we interrogate the consequences of chronic necroptosis on immune homeostasis by deleting Ripk1 in mouse dendritic cells. We demonstrate that deregulated necroptosis results in systemic inflammation, tissue fibrosis, and autoimmunity. We show that inflammation and autoimmunity are prevented upon expression of kinase inactive RIPK1 or deletion of RIPK3 or MLKL. We provide evidence that the inflammation is not driven by microbial ligands, but depends on the release of danger-associated molecular patterns and MyD88-dependent signaling. Importantly, although the inflammation is independent of type I IFN and the nucleic acid sensing TLRs, blocking these pathways rescues the autoimmunity. These mouse genetic studies reveal that chronic necroptosis may underlie human fibrotic and autoimmune disorders.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Autoimmunity / Receptor-Interacting Protein Serine-Threonine Kinases / Immunity / Inflammation Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Immunol Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Autoimmunity / Receptor-Interacting Protein Serine-Threonine Kinases / Immunity / Inflammation Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Immunol Year: 2018 Document type: Article